Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FLAVONE ACETIC ACID' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Determination of unbound concentration of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human plasma by ultrafiltration followed by high-performance liquid chromatography with fluorimetric detection

      JOURNAL OF CHROMATOGRAPHY B
    3. Mukherjee, S; Kumar, W; Prasad, AK; Raj, HG; Bracke, ME; Olsen, CE; Jain, SC; Parmar, VS
      Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones

      BIOORGANIC & MEDICINAL CHEMISTRY
    4. Philpott, M; Ching, LM; Baguley, BC
      The antitumour agent 5,6-dimethylxanthenone-4-acetic acid acts in vitro onhuman mononuclear cells as a co-stimulator with other inducers of tumour necrosis factor

      EUROPEAN JOURNAL OF CANCER
    5. Murata, R; Overgaard, J; Horsman, MR
      Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    6. Murata, R; Overgaard, J; Horsman, MR
      Combretastatin A-4 disodium phosphate: A vascular targeting agent that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    7. Zhao, LL; Kestell, P; Philpott, M; Ching, LM; Zhuang, L; Baguley, BC
      Effects of the serotonin receptor antagonist cyproheptadine on the activity and pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    8. Zhou, S; Paxton, JW; Kestell, P; Tingle, MD; Ching, LM
      In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Zhou, SF; Chin, R; Kestell, P; Tingle, MD; Paxton, JW
      Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Horsman, MR; Murata, R; Overgaard, J
      Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation

      ACTA ONCOLOGICA
    11. Murata, R; Overgaard, J; Horsman, MR
      Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    12. Murata, R; Siemann, DW; Overgaard, J; Horsman, MR
      Interaction between combretastatin A-4 disodium phosphate and radiation inmurine tumors

      RADIOTHERAPY AND ONCOLOGY
    13. Zhou, SF; Paxton, JW; Tingle, ID; Kestell, P; Jameson, MB; Thompson, PI; Baguley, BC
      Identification and reactivity of the major metabolite (beta-1-glucuronide)of the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in humans

      XENOBIOTICA
    14. Murata, R; Siemann, DW; Overgaard, J; Horsman, MR
      Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid

      RADIATION RESEARCH
    15. Zhou, SF; Paxton, JW; Kestell, P; Tingle, MD
      Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    16. Kanwar, JR; Kanwar, RK; Pandey, S; Ching, LM; Krissansen, GW
      Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1(CD80)-mediated immunotherapy overcomes immune resistance and leads to theeradication of large tumors and multiple tumor foci

      CANCER RESEARCH
    17. Cao, ZH; Baguley, BC; Ching, LM
      Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

      CANCER RESEARCH
    18. Denny, WA; Wilson, WR
      Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    19. Valenti, P; Bisi, A; Rampa, A; Belluti, F; Gobbi, S; Zampiron, A; Carrara, M
      Synthesis and biological activity of some rigid analogues of flavone-8-acetic acid

      BIOORGANIC & MEDICINAL CHEMISTRY
    20. Landuyt, W; Verdoes, O; Darius, DO; Drijkoningen, M; Nuyts, S; Theys, J; Stockx, L; Wynendaele, W; Fowler, JF; Maleux, G; Van den Bogaert, W; Anne, J; van Oosterom, A; Lambin, P
      Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas

      EUROPEAN JOURNAL OF CANCER
    21. Hori, K; Saito, S; Takahashi, H; Sato, H; Maeda, H; Sato, Y
      Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride

      JAPANESE JOURNAL OF CANCER RESEARCH
    22. Vicaut, E; Laemmel, E; Stucker, O
      Impact of serotonin on tumour growth

      ANNALS OF MEDICINE
    23. Aitken, RA; Bibby, MC; Cooper, PA; Double, JA; Laws, AL; Ritchie, RB; Wilson, DWJ
      Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 4: Variation of the basic structure

      ARCHIV DER PHARMAZIE
    24. Kestell, P; Zhao, LL; Baguley, BC; Palmer, BD; Muller, G; Paxton, JW; Ching, LM
      Modulation of the pharmacokinetics of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice by thalidomide

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    25. Harris, SR; Panaro, NJ; Thorgeirsson, UP
      Oxidative stress contributes to the anti-proliferative effects of flavone acetic acid on endothelial cells

      ANTICANCER RESEARCH
    26. Siemann, DW; Warrington, KH; Horsman, MR
      Targeting tumor blood vessels: an adjuvant strategy for radiation therapy

      RADIOTHERAPY AND ONCOLOGY
    27. Zhou, SF; Paxton, JW; Tingle, MD; Kestell, P
      Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid

      DRUG METABOLISM AND DISPOSITION
    28. Tuncbilek, M; Ayhan-Kilcigil, G; Ertan, R; Can-Eke, B; Iscan, M
      Synthesis and antioxidant properties of some new flavone derivatives on lipid peroxidation in the rat liver

      PHARMAZIE
    29. Siim, BG; Laux, WT; Rutland, MD; Palmer, BN; Wilson, WR
      Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2 '-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (Tc-99m-labeled HL-91; Prognox): Noninvasive detection of tumor response to the antivascular agent5,6-dimethylxanthenone-4-acetic acid

      CANCER RESEARCH
    30. Zhou, SF; Paxton, JW; Tingle, MD; McCall, J; Kestell, P
      Determination of two major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in hepatic microsomal incubations by high-performance liquid chromatography with fluorescence detection

      JOURNAL OF CHROMATOGRAPHY B
    31. Sersa, G; Cemazar, M; Parkins, CS; Chaplin, DJ
      Tumour blood flow changes induced by application of electric pulses

      EUROPEAN JOURNAL OF CANCER
    32. Nihei, Y; Suga, Y; Morinaga, Y; Ohishi, K; Okano, A; Ohsumi, K; Hatanaka, T; Nakagawa, R; Tsuji, T; Akiyama, Y; Saito, S; Hori, K; Sato, Y; Tsuruo, T
      A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors

      JAPANESE JOURNAL OF CANCER RESEARCH
    33. Hori, K; Saito, S; Nihei, Y; Suzuki, M; Sato, Y
      Antitumor effects due to irreversible stoppage of tumor tissue blood flow:Evaluation of a novel combretastatin A-4 derivative, AC7700

      JAPANESE JOURNAL OF CANCER RESEARCH
    34. Nihei, Y; Suzuki, M; Okano, A; Tsuji, T; Akiyama, Y; Tsuruo, T; Saito, S; Hori, K; Sato, Y
      Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy

      JAPANESE JOURNAL OF CANCER RESEARCH
    35. Kestell, P; Paxton, JW; Rewcastle, GW; Dunlop, I; Baguley, BC
      Plasma disposition, metabolism and excretion of the experimental antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the mouse, rat acid rabbit

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    36. Shakil, A; Ogawa, A; Griffin, RJ; Song, CW
      Reduction of tumour blood flow with KB-R8498 potentiates the response of tumours to hyperthermia

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    37. Chaplin, DJ; Pettit, GR; Hill, SA
      Anti-vascular approaches to solid tumour therapy: Evaluation of combretastatin A4 phosphate

      ANTICANCER RESEARCH
    38. Kawaguchi, K; Kikuchi, S; Takayanagi, K; Yoshikawa, T; Kumazawa, Y
      Colony stimulating factor-inducing activity of hesperidin

      PLANTA MEDICA
    39. Tozer, GM; Prise, VE; Wilson, J; Locke, RJ; Vojnovic, B; Stratford, MRL; Dennis, MF; Chaplin, DJ
      Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues

      CANCER RESEARCH
    40. Joseph, WR; Cao, ZH; Mountjoy, KG; Marshall, ES; Baguley, BC; Ching, LM
      Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: A novel approach to cancer therapy

      CANCER RESEARCH
    41. Grosios, K; Holwell, SE; McGown, AT; Pettit, GR; Bibby, MC
      In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

      BRITISH JOURNAL OF CANCER
    42. Newell, DR; Burtles, SS; Fox, BW; Jodrell, DI; Connors, TA
      Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics

      BRITISH JOURNAL OF CANCER
    43. Cao, Z; Joseph, WR; Browne, WL; Mountjoy, KG; Palmer, BD; Baguley, BC; Ching, LM
      Thalidomide increases both intra-tumoural tumour necrosis factor-alpha production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid

      BRITISH JOURNAL OF CANCER
    44. Panaro, NJ; Popescu, NC; Harris, SR; Thorgeirsson, UP
      Flavone acetic acid induces a G2/M cell cycle arrest in mammary carcinoma cells

      BRITISH JOURNAL OF CANCER
    45. Chaplin, DJ; Dougherty, GJ
      Tumour vasculature as a target for cancer therapy

      BRITISH JOURNAL OF CANCER
    46. Bibby, MC
      Making the most of rodent tumour systems in cancer drug discovery

      BRITISH JOURNAL OF CANCER
    47. Phillips, RM
      Inhibition of DT-diaphorase (NAD(P)H : quinone oxidoreductase, EC 1.6.99.2) by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and flavone-8-acetic acid(FAA): Implications for bioreductive drug development

      BIOCHEMICAL PHARMACOLOGY
    48. CHAPLIN DJ; HILL SA; BELL KM; TOZER GM
      MODIFICATION OF TUMOR BLOOD-FLOW - CURRENT STATUS AND FUTURE-DIRECTIONS

      Seminars in radiation oncology
    49. PANG JH; CAO Z; JOSEPH WR; BAGULEY BC; CHING LM
      ANTITUMOR-ACTIVITY OF THE NOVEL IMMUNE MODULATOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA) IN MICE LACKING THE INTERFERON-GAMMA RECEPTOR

      European journal of cancer
    50. ONO K; MASUNAGA S; KINASHI Y; TAKAGAKI M; AKABOSHI M; SUZUKI M; BABA H
      EFFECTS OF BORON NEUTRON-CAPTURE THERAPY USING BOROCAPTATE SODIUM IN COMBINATION WITH A TUMOR-SELECTIVE VASOACTIVE AGENT IN MICE

      Japanese journal of cancer research
    51. SENDEROWICZ AM; HEADLEE D; STINSON SF; LUSH RM; KALIL N; VILLALBA L; HILL K; STEINBERG SM; FIGG WD; TOMPKINS A; ARBUCK SG; SAUSVILLE EA
      PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS

      Journal of clinical oncology
    52. PARMAR VS; JAIN SC; BISHT KS; SHARMA NK; HIMANSHU; GUPTA S
      SYNTHESIS AND ANTI-INVASIVE ACTIVITY OF NOVEL 1,3-DIARYLPROPENONES

      Indian journal of chemistry. Sect. B: organic chemistry, including medical chemistry
    53. Aitken, RA; Bibby, MC; Bielefeldt, F; Double, JA; Laws, AL; Mathieu, AL; Ritchie, RB; Wilson, DWJ
      Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 3: 2-heteroaryl derivatives

      ARCHIV DER PHARMAZIE
    54. MAXWELL RJ; NIELSEN FU; BREIDAHL T; STODKILDEJORGENSEN H; HORSMAN MR
      EFFECTS OF COMBRETASTATIN ON MURINE TUMORS MONITORED BY P-31 MRS, H-1MRS AND H-1 MRI

      International journal of radiation oncology, biology, physics
    55. LI LY; ROJIANI A; SIEMANN DW
      TARGETING THE TUMOR VASCULATURE WITH COMBRETASTATIN A-4 DISODIUM PHOSPHATE - EFFECTS ON RADIATION-THERAPY

      International journal of radiation oncology, biology, physics
    56. WILSON WR; LI AE; COWAN DSM; SIIM BG
      ENHANCEMENT OF TUMOR RADIATION RESPONSE BY THE ANTIVASCULAR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID

      International journal of radiation oncology, biology, physics
    57. Valenti, P; Bisi, A; Rampa, A; Gobbi, S; Belluti, F; Da Re, P; Cima, L; Carrara, M
      Synthesis of flavone-2 '-carboxylic acid analogues as potential antitumor agents

      ANTI-CANCER DRUG DESIGN
    58. Browne, WL; Wilson, WR; Baguley, BC; Ching, LM
      Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid

      ANTICANCER RESEARCH
    59. MORGAN CD; LEFKOWITZ SS; EVERSE J
      SYNERGISM OF DIMETHOXYBENZOSEMIQUINONE FREE-RADICALS AND CD4-LYMPHOCYTES TO SUPPRESS EHRLICH ASCITES TUMOR( T)

      Proceedings of the Society for Experimental Biology and Medicine
    60. LASH CJ; LI AE; RUTLAND M; BAGULEY BC; ZWI LJ; WILSON WR
      ENHANCEMENT OF THE ANTITUMOR EFFECTS OF THE ANTIVASCULAR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA) BY COMBINATION WITH 5-HYDROXYTRYPTAMINE AND BIOREDUCTIVE DRUGS

      British Journal of Cancer
    61. CHING LM; BROWNE WL; TCHERNEGOVSKI R; GREGORY T; BAGULEY BC; PALMER BD
      INTERACTION OF THALIDOMIDE, PHTHALIMIDE ANALOGS OF THALIDOMIDE AND PENTOXIFYLLINE WITH THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID - CONCOMITANT REDUCTION OF SERUM TUMOR-NECROSIS-FACTOR-ALPHA AND ENHANCEMENT OF ANTITUMOR-ACTIVITY

      British Journal of Cancer
    62. MOILANEN E; THOMSEN LL; MILES DW; HAPPERFIELD L; KNOWLES RG; MONCADA S
      PERSISTENT INDUCTION OF NITRIC-OXIDE SYNTHASE IN TUMORS FROM MICE TREATED WITH THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID

      British Journal of Cancer
    63. MOLEMA G; MEIJER DKF; DELEIJ LFMH
      TUMOR VASCULATURE TARGETED THERAPIES - GETTING THE PLAYERS ORGANIZED

      Biochemical pharmacology
    64. YOUNG HA
      INTERFERON EXPRESSION BY B-CELLS

      Methods
    65. VINCENT PW; ROBERTS BJ; ELLIOTT WL; LEOPOLD WR
      CHEMOTHERAPY WITH DMXAA (5,6-DIMETHYLXANTHENONE-4-ACETIC ACID) IN COMBINATION WITH CI-1010 ROMOETHYL)AMINO]METHYL]-2-NITRO-,MONO-HYDROBROMIDE (R-ISOMER)) AGAINST ADVANCED-STAGE MURINE COLON-CARCINOMA-26

      Oncology Reports
    66. SIIM BG; DENNY WA; WILSON WR
      NITRO REDUCTION AS AN ELECTRONIC SWITCH FOR BIOREDUCTIVE DRUG ACTIVATION

      Oncology research
    67. BAGULEY BC; ZHUANG L; KESTELL P
      INCREASED PLASMA SEROTONIN FOLLOWING TREATMENT WITH FLAVONE-8-ACETIC ACID, 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, VINBLASTINE, AND COLCHICINE - RELATION TO VASCULAR EFFECTS

      Oncology research
    68. TAKEUCHI H; BABA H; INUTSUKA S; MAEHARA Y; SUGIMACHI K
      POTENTIATION OF THE CYTOTOXICITY OF CARBOQUONE BY FLAVONE ACETIC-ACIDCOMBINED WITH HYPERTHERMIA

      Anti-cancer drugs
    69. EXON JH; SOUTH EH; HENDRIX K
      THE EFFECT OF BIOCHANIN-A ON IMMUNE FUNCTION IN RATS AND TUMOR-CELL GROWTH AND VIABILITY

      FOOD AND AGRICULTURAL IMMUNOLOGY
    70. AITKEN RA; BIBBY MC; DOUBLE JA; LAWS AL; RITCHIE RB; WILSON DWJ
      SYNTHESIS AND ANTITUMOR-ACTIVITY OF NEW DERIVATIVES OF FLAVONE-8-ACETIC ACID (FAA) .2. RING-SUBSTITUTED DERIVATIVES

      Archiv der pharmazie
    71. MUELLERKLIESER W
      3-DIMENSIONAL CELL-CULTURES - FROM MOLECULAR MECHANISMS TO CLINICAL-APPLICATIONS

      American journal of physiology. Cell physiology
    72. PRUIJN FB; VANDAALEN M; HOLFORD NHG; WILSON WR
      MECHANISMS OF ENHANCEMENT OF THE ANTITUMOR-ACTIVITY OF MELPHALAN BY THE TUMOR-BLOOD-FLOW INHIBITOR 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID

      Cancer chemotherapy and pharmacology
    73. HAMMAD HM; ABDALLA SS
      PHARMACOLOGICAL EFFECTS OF SELECTED FLAVONOIDS ON RAT ISOLATED ILEUM - STRUCTURE-ACTIVITY RELATIONSHIP

      General pharmacology
    74. BRANSOVA J; UHER M; NOVOTNY L; BRTKO J
      5-BENZYLOXY-2-THIOCYANATOMETHYL-4-PYRANONE, A NOVEL HETEROCYCLIC COMPOUND - SYNTHESIS, STRUCTURE DETERMINATION AND EFFECTS ON NEOPLASTIC CELL-GROWTH

      Anticancer research
    75. PATEL S; PARKIN SM; BIBBY MC
      THE EFFECT OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID ON TUMOR-NECROSIS-FACTOR PRODUCTION BY HUMAN IMMUNE CELLS

      Anticancer research
    76. DAUZONNE D; FOLLEAS B; MARTINEZ L; CHABOT GG
      SYNTHESIS AND IN-VITRO CYTOTOXICITY OF A SERIES OF 3-AMINOFLAVONES

      European journal of medicinal chemistry
    77. THOMSEN LL; SCOTT JMJ; TOPLEY P; KNOWLES RG; KEERIE AJ; FREND AJ
      SELECTIVE-INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE INHIBITS TUMOR-GROWTH IN-VIVO - STUDIES WITH 1400W, A NOVEL INHIBITOR

      Cancer research
    78. DARK GG; HILL SA; PRISE VE; TOZER GM; PETTIT GR; CHAPLIN DJ
      COMBRETASTATIN A-4, AN AGENT THAT DISPLAYS POTENT AND SELECTIVE TOXICITY TOWARD TUMOR VASCULATURE

      Cancer research
    79. BUTLER SA; WOOD PJ; COLE S; WILLIAMS C; ADAMS GE; STRATFORD IJ
      ENHANCEMENT OF BIOREDUCTIVE DRUG TOXICITY IN MURINE TUMORS BY INHIBITION OF THE ACTIVITY OF NITRIC-OXIDE SYNTHASE

      British Journal of Cancer
    80. PHILPOTT M; JOSEPH WR; CROSIER KE; BAGULEY BC; CHING LM
      PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY CULTURED HUMAN PERIPHERAL-BLOOD LEUKOCYTES IN RESPONSE TO THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (NSC-640488)

      British Journal of Cancer
    81. HARRIS SR; THORGEIRSSON UP
      FLAVONE ACETIC-ACID STIMULATES NITRIC-OXIDE AND PEROXYNITRITE PRODUCTION IN SUBCUTANEOUS MOUSE-TUMORS

      Biochemical and biophysical research communications
    82. EVERETT SA; DENNIS MF; PATEL KB; WARDMAN P; STRATFORD MRL
      HIGH-PERFORMANCE ION CHROMATOGRAPHY APPLIED TO FREE-RADICAL MECHANISMS IN DRUG DESIGN - THE PROBLEM OF ION ANALYSIS AT HIGH IONIC STRENGTHS

      Journal of chromatography
    83. BAGULEY BC; CHING LM
      IMMUNOMODULATORY ACTIONS OF XANTHENONE ANTICANCER AGENTS

      Biodrugs
    84. LIN PS; HO KC; TSAI S
      TUMOR-NECROSIS-FACTOR-ALPHA SUPPRESSES THE REGROWTH OF FRACTIONATED IRRADIATED ENDOTHELIAL-CELLS IN-VITRO

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    85. BROWN JM; SUM BG
      HYPOXIA-SPECIFIC CYTOTOXINS IN CANCER-THERAPY

      Seminars in radiation oncology
    86. SEDLACEK HH; CZECH J; NAIK R; KAUR G; WORLAND P; LOSIEWICZ M; PARKER B; CARLSON B; SMITH A; SENDEROWICZ A; SAUSVILLE E
      FLAVOPIRIDOL (L86-8275,NSC-649890), A NEW KINASE INHIBITOR FOR TUMOR-THERAPY

      International journal of oncology
    87. DALESSANDRO N; BORSELLINO N
      IN-VIVO EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA OR FLAVONE ACETIC-ACIDIN COMBINATION WITH DOXORUBICIN ON MULTIDRUG-RESISTANT B16 MELANOMA

      Anti-cancer drugs
    88. BURKE F; BALKWILL FR
      CYTOKINES IN ANIMAL-MODELS OF CANCER

      Biotherapy
    89. AITKEN RA; BIBBY MC; DOUBLE JA; PHILLIPS RM; SHARMA SK
      SYNTHESIS AND ANTITUMOR-ACTIVITY OF NEW DERIVATIVES OF FLAVONE-8-ACETIC ACID (FAA) .1. 6-METHYL DERIVATIVES

      Archiv der pharmazie
    90. TAKEUCHI H; BABA H; MAEHARA Y; SUGIMACHI K; NEWMAN RA
      FLAVONE ACETIC-ACID INCREASES THE CYTOTOXICITY OF MITOMYCIN-C WHEN COMBINED WITH HYPERTHERMIA

      Cancer chemotherapy and pharmacology
    91. VALENTI P; FABBRI G; RAMPA A; BISI A; GOBBI S; DARE P; CARRARA M; SGEVANO A; CIMA L
      SYNTHESIS AND ANTITUMOR-ACTIVITY OF SOME ANALOGS OF FLAVONE ACETIC-ACID

      Anti-cancer drug design
    92. HORSMAN MR; SAMPSON LE; CHAPLIN DJ; OVERGAARD J
      THE IN-VIVO INTERACTION BETWEEN FLAVONE ACETIC-ACID AND HYPERTHERMIA

      International journal of hyperthermia
    93. YAMAMOTO M; KUSUMOTO T; ENDO K; BABA H; SAKAGUCHI Y; MAEHARA Y; SUGIMACHI K
      VASOACTING AGENTS FLAVONE ACETIC-ACID AND HYDRALAZINE GIVEN IN COMBINATION ENHANCE ANTITUMOR EFFECTS UNDER CONDITION OF HYPERTHERMIA

      Oncology
    94. PEDLEY RB; BODEN JA; BODEN R; BOXER GM; FLYNN AA; KEEP PA; BEGENT RHJ
      ABLATION OF COLORECTAL XENOGRAFTS WITH COMBINED RADIOIMMUNOTHERAPY AND TUMOR BLOOD FLOW-MODIFYING AGENTS

      Cancer research
    95. CHAPLIN DJ; PETTIT GR; PARKINS CS; HILL SA
      ANTIVASCULAR APPROACHES TO SOLID TUMOR-THERAPY - EVALUATION OF TUBULIN BINDING-AGENTS

      British Journal of Cancer
    96. WATTS ME; ARNOLD S; CHAPLIN DJ
      CHANGES IN COAGULATION AND PERMEABILITY PROPERTIES OF HUMAN ENDOTHELIAL-CELLS IN-VITRO INDUCED BY TNF-ALPHA OR 5,6-MEXAA

      British Journal of Cancer
    97. PHILPOTT M; BAGULEY BC; CHING LM
      INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY SINGLE AND REPEATED DOSESOF THE ANTITUMOR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID

      Cancer chemotherapy and pharmacology
    98. VESZELOVSZKY E; HOLFORD NHG; THOMSEN LL; KNOWLES RG; BAGULEY BC
      PLASMA NITRATE CLEARANCE IN MICE - MODELING OF THE SYSTEMIC PRODUCTION OF NITRATE FOLLOWING THE INDUCTION OF NITRIC-OXIDE SYNTHESIS

      Cancer chemotherapy and pharmacology
    99. DEFORNI M; CHABOT GG; ARMAND JP; GOUYETTE A; KLINKALAK M; RECONDO G
      PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION

      Cancer chemotherapy and pharmacology
    100. WILSON WR; PRUIJN FB
      HYPOXIA-ACTIVATED PRODRUGS AS ANTITUMOR AGENTS - STRATEGIES FOR MAXIMIZING TUMOR-CELL KILLING

      Clinical and experimental pharmacology and physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 23:33:17